Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need.

被引：0
|
作者：
Jadersten, Martin
Malcovati, Luca
Dybedal, Ingunn
Della Porta, Matteo Giovanni
Invernizzi, Rosangela
Montgomery, Scott M.
Pascutto, Cristiana
Porwit-MacDonald, Anna
Cazzola, Mario
Hellstrom-Lindberg, Eva
机构：
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Stockholm, Sweden
[2] Univ Pavia, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[3] Univ Oslo, Ullevaal Hosp, Dept Med, N-0407 Oslo, Norway
[4] Univ Pavia, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[5] Karolinska Univ Hosp Solna, Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden
[6] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Pathol, Stockholm, Sweden
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
521
引用
收藏
页码：158A / 158A
页数：1
相关论文
共 50 条
  • [41] G-CSF TREATMENT IN FANCONI'S ANEMIA PATIENTS. 139
    P Scagni
    P Saracco
    L Farinasso
    M Dall'Aglio
    C Gaglioti
    A P Barone
    N Crescenzio
    F Timeus
    U Ramenghi
    Pediatric Research, 1997, 41 (5) : 773 - 773
  • [42] Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need.
    Olivìeri, A
    Spitaleri, L
    Gini, G
    Montanari, M
    Capelli, D
    Lucesole, M
    Scortechini, I
    Poloni, A
    Pasquini, R
    Masia, MC
    Leoni, P
    BLOOD, 2002, 100 (11) : 398B - 398B
  • [43] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [44] ADDITION OF PLERIXAFOR TO G-CSF IMPROVES THE GRAFT CONTENT IN SIDE POPULATION (SP) WITH IMMATURE PHENOTYPE IN PATIENTS THAT FAILED TO RESPOND WELL TO G-CSF ALONE.
    Bijou, F.
    de la Grange, P. Brunet
    Rodriguez, L.
    Schmitt, A.
    Adiko, D.
    Bouzgarrou, R.
    Milpied, N.
    Bouabdallah, K.
    Lascaux, A.
    Dazey, B.
    Lettelier, C.
    Duchez, P.
    Vlaski, M.
    Boiron, J. M.
    Ivanovic, Z.
    HAEMATOLOGICA, 2014, 99 : 177 - 177
  • [45] Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia
    Yetgin, S
    Ozbek, N
    TURKISH JOURNAL OF PEDIATRICS, 1998, 40 (03) : 421 - 424
  • [46] G-CSF increases hematological response and survival among patients with myelodysplasia treated with azacitidine
    Falke, E.
    Rossetti, J. M.
    Shadduck, R. K.
    Kaplan, R. B.
    Kennedy, M.
    Juvvadi, R.
    Kramer, W.
    Lister, J.
    LEUKEMIA RESEARCH, 2007, 31 : S123 - S124
  • [47] Treatment of the anemia in MDS with G-CSF and EPO: Final report from a randomized phase II study.
    HellstromLindberg, E
    Tangen, JM
    Grimfors, G
    Lindemalm, C
    Carlsson, M
    Oberg, G
    Lowenberg, E
    Linder, O
    Dybedal, I
    Dahl, IM
    NilssonEhle, H
    Ahlgren, T
    Winquist, I
    Carneskog, J
    Luthman, M
    BLOOD, 1996, 88 (10) : 1805 - 1805
  • [48] The effects of G-CSF on survival of AML patients after autologus blood and marrow transplantation
    Ghavamzadeh, A
    Irvani, M
    Bahar, B
    Jahani, M
    Alimoghaddam, K
    Yunesian, M
    Gholibeikian, S
    Samiee, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 393 - 393
  • [49] Changes in the flowcytometric dysplasia score during treatment with erythropoietin/G-CSF reflect responses in low/int-l risk myelodysplastic syndromes
    Westers, T. M.
    Chamuleau, M. E. D.
    Westra, A. H.
    Drager, A. M.
    Ossenkoppele, G. J.
    van de Loosdrecht, A. A.
    LEUKEMIA RESEARCH, 2007, 31 : S90 - S90
  • [50] Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells
    Altundag, K
    Altundag, O
    Elkiran, ET
    Cengiz, M
    Ozisik, Y
    MEDICAL HYPOTHESES, 2004, 63 (01) : 56 - 58
12345